InsidersTradesSigma
Total declarations
Company
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Browse the detailed record of transactions filed by Sarma Purnanand D, Chief Executive Officer. Officer active across 1 companies, notably Immunome Inc.. Cumulatively, 2 reports have been logged. Total volume traded: €316k. The latest transaction was filed on 25 May 2021 (Acquisition). Regulator: SEC (Form 4). All data is free.
Declarations2 total
€157,81210,500 shares@ €15.0297100.0% of flow
Common Stock
SEC:0001104659-21-072618·
Ideal exit: 19 Feb 2022 (T+270)
€157,81210,500 shares@ €15.02970.0067% mcap50.0% of flow
Common Stock
SEC:0001104659-21-072618:0·
Ideal exit: 19 Feb 2022 (T+270)
2 of 2 declarations
About Sarma Purnanand D
Purnanand D. Sarma is the President and CEO of Immunome Inc. In this role, he is responsible for the strategic and operational leadership of the company. Purnanand Sarma plays a key role in developing new therapeutic solutions and optimizing the company's performance. His expertise in biotechnology and management is essential for the success of Immunome.
